Activating mutations of Notch1 drive oncogenesis in T-cell acute lymphoblastic leukemia through upregulation of Myc and NF-κB, while in breast cancer, nonsmall-cell lung cancer, and gliomas, Notch receptors promote proliferation, apoptosis resistance, and cancer stem cell maintenance. This evidence concerns the gene NOTCH1 and breast cancer.